bw a1433u has been researched along with ritanserin in 1 studies
| Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 735 | 75 | 71 |
| Protein | Taxonomy | bw a1433u (IC50) | ritanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrara, JJ; Flint, LM; Force, SD; Franklin, EW; Hyman, AL; Lippton, HL; Taheri, PA | 1 |
1 other study(ies) available for bw a1433u and ritanserin
| Article | Year |
|---|---|
Analysis of regional hemodynamic regulation in response to scald injury.
Topics: Adamantane; Animals; Arginine; Atropine; Blood Pressure; Burns; Diphenhydramine; Dogs; Femoral Artery; Hemodynamics; Hindlimb; Histamine; Isoproterenol; Meclofenamic Acid; Methoxamine; Methysergide; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pulmonary Circulation; Ranitidine; Regional Blood Flow; Ritanserin; Serotonin; Serotonin Receptor Agonists; Time Factors; Triazines; Ultrasonography; Vascular Resistance; Vasodilation; Verapamil; Xanthines | 1994 |